Assembly Biosciences (ASMB) Non-Current Deferred Tax Liability (2014 - 2021)

Assembly Biosciences' Non-Current Deferred Tax Liability history runs 8 years deep, the most recent figure standing at $2.5 million for Q3 2021.

• In Q3 2021, Non-Current Deferred Tax Liability changed 0.0% year-over-year to $2.5 million; the TTM figure through Sep 2021 stood at $2.5 million (changed 0.0% YoY), while the FY2020 annual figure was $2.5 million, changed 0.0% from the prior year.
• Non-Current Deferred Tax Liability for Q3 2021 stood at $2.5 million, roughly flat from $2.5 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $3.3 million in Q4 2018, with the low at $2.1 million in Q4 2017.
• The 5-year median for Non-Current Deferred Tax Liability is $2.5 million (2019), against an average of $2.7 million.
• The sharpest annual moves came in 2017 and 2018: Non-Current Deferred Tax Liability sank 80.79% in 2017, then jumped 52.25% in 2018.
• Assembly Biosciences' Non-Current Deferred Tax Liability stood at $2.1 million in 2017, then surged by 52.25% to $3.3 million in 2018, then retreated by 22.17% to $2.5 million in 2019, then changed by 0.0% to $2.5 million in 2020, then changed by 0.0% to $2.5 million in 2021.
• Business Quant data shows ASMB's Non-Current Deferred Tax Liability at $2.5 million in Q3 2021, $2.5 million in Q2 2021, and $2.5 million in Q1 2021.